Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMSC fibrin matrix for chronic lower-limb wounds
2019-004637-16Phase 2Active
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Nov 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CSCC_ASC in Chronic wound, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoint: Treatment-related complication rate. Started Nov 2020; status: active.
02
Drugs
CSCC_ASC
03
Conditions
Chronic wound
Beyond the preview
Go deeper on 2019-004637-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004637-16.